12 results on '"Aitken, Dawn"'
Search Results
2. Effect of Intravenous Zoledronic Acid on Total Knee Replacement in Patients With Symptomatic Knee Osteoarthritis and Without Severe Joint Space Narrowing: A Prespecified Secondary Analysis of a Two‐Year, Multicenter, Double‐Blind, Placebo‐Controlled Clinical Trial
- Author
-
Cai, Guoqi, Laslett, Laura L., Thompson, Michael, Cicuttini, Flavia, Hill, Catherine, Wluka, Anita E., March, Lyn, Wang, Yuanyuan, Otahal, Petr, Stoney, James D., Antony, Benny, Buttigieg, Kathy, Winzenberg, Tania, Jones, Graeme, and Aitken, Dawn
- Subjects
KNEE osteoarthritis ,DIPHOSPHONATES ,RESEARCH funding ,DESCRIPTIVE statistics ,INTRAVENOUS therapy ,KNEE joint ,PRE-tests & post-tests ,ZOLEDRONIC acid ,TOTAL knee replacement ,PAIN management ,CONFIDENCE intervals ,DATA analysis software ,PROPORTIONAL hazards models - Abstract
Objective: To determine the effect of zoledronic acid (ZA) on the risk of total knee replacement (TKR) in patients with symptomatic knee osteoarthritis and without severe joint space narrowing (JSN). Methods: We included 222 participants (mean age 62 years, 52% female) from the two‐year Zoledronic Acid for Osteoarthritis Knee Pain trial (113 received 5 mg of ZA annually and 109 received placebo) conducted between November 2013 and October 2017. Primary TKR were identified until February 22, 2022. The effect of ZA on TKR risk was evaluated using Cox proportional hazard regression models. Because the treatment effect failed the proportional hazards assumption, a time‐varying coefficients analysis for treatment was conducted by splitting the study into two periods (ie, within and after two years of randomization). Results: Over a mean follow‐up of seven years, 39% and 30% of participants had any TKR in the ZA and placebo groups, and 28% and 18% had TKR in the study knee, respectively. Use of ZA was associated with a higher risk of TKR in any knee (hazard ratio [HR] 4.2, 95% confidence interval [CI] 1.2–14.7) and showed a trend in the study knee (HR 6.8, 95%CI 0.9–53.9) during the trial. In the posttrial period, the risk of TKR was similar in the ZA and the placebo groups for any knee (HR 1.2, 95%CI 0.5–1.8) and the study knee (HR 1.4, 95%CI 0.5–2.2). Conclusion: These results suggest that ZA is not protective against TKR in patients with symptomatic knee osteoarthritis and without severe JSN. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Depression in patients with knee osteoarthritis: risk factors and associations with joint symptoms
- Author
-
Zheng, Shuang, Tu, Liudan, Cicuttini, Flavia, Zhu, Zhaohua, Han, Weiyu, Antony, Benny, Wluka, Anita E., Winzenberg, Tania, Aitken, Dawn, Blizzard, Leigh, Jones, Graeme, and Ding, Changhai
- Published
- 2021
- Full Text
- View/download PDF
4. A Randomised Controlled Trial of YOG a and Strengthening Exercise for Knee Osteo A rthritis: Protocol for a Comparative Effectiveness Trial (YOGA Trial).
- Author
-
Singh, Ambrish, Aitken, Dawn, Moonaz, Steffany, Palmer, Andrew J., Blizzard, Leigh, Ding, Changhai, Drummen, Stan, Jones, Graeme, Bennell, Kim, and Antony, Benny
- Subjects
YOGA ,RANDOMIZED controlled trials ,STRENGTH training ,EXERCISE therapy ,PHYSICAL mobility ,MUSCLE strength - Abstract
Osteoarthritis (OA) is a common joint disorder for which there is no cure. Current treatments are suboptimal. Exercise is a core treatment for knee OA, with muscle strengthening exercise commonly recommended. Yoga is a mind-body exercise intervention that can improve flexibility, muscle strength, balance, and fitness and potentially reduce symptoms of OA. However, there is a scarcity of robust, high-quality conclusive evidence on the efficacy of yoga in knee OA. We are currently conducting the first randomised comparative effectiveness and cost-effectiveness trial of a yoga program compared with a strengthening exercise program in patients with symptomatic knee OA. This study protocol describes the design and conduct of this trial. The YOGA study is a phase III, single-centre, parallel, superiority, randomised, active-controlled trial which will be conducted in Hobart, Australia. One hundred and twenty-six participants (63 in each arm) aged over 40 years with symptomatic knee OA will be recruited from the community and randomly allocated to receive either a 24-week yoga program (3×/week) or a strengthening exercise program (3×/week). The primary outcome will be change in knee pain over 12 weeks, assessed using a 100 mm visual analogue scale (VAS). The secondary outcomes include change in knee pain, patient global assessment, physical function, quality of life, gait speed, biomarkers, and others over 12 and 24 weeks. We will also assess whether the presence of neuropathic pain moderates the effects of yoga compared to strengthening exercise. Additional data, such as cost and resource utilization, will be collected for the cost-effectiveness analysis. The primary analysis will be conducted using an intention-to-treat approach. Adverse events will be monitored throughout the study. Once completed, this trial will contribute to the knowledge of whether yoga can be used as a simple, effective, low-cost option for the management of knee OA, thus saving economic costs in the healthcare system. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Serum Metabolomic Signatures for Knee Cartilage Volume Loss over 10 Years in Community-Dwelling Older Adults.
- Author
-
Xie, Zikun, Aitken, Dawn, Liu, Ming, Lei, Guanghua, Jones, Graeme, Cicuttini, Flavia, and Zhai, Guangju
- Subjects
- *
KNEE , *CARTILAGE , *ARTICULAR cartilage , *METABOLOMICS , *JOINT diseases , *ADULTS - Abstract
Osteoarthritis (OA) is the most prevalent joint disorder characterized by joint structural pathological changes with the loss of articular cartilage as its hallmark. Tools that can predict cartilage loss would help identify people at high risk, thus preventing OA development. The recent advance of the metabolomics provides a new avenue to systematically investigate metabolic alterations in disease and identify biomarkers for early diagnosis. Using a metabolomics approach, the current study aimed to identify serum metabolomic signatures for predicting knee cartilage volume loss over 10 years in the Tasmania Older Adult Cohort (TASOAC). Cartilage volume was measured in the medial, lateral, and patellar compartments of the knee by MRI at baseline and follow-up. Changes in cartilage volume over 10 years were calculated as percentage change per year. Fasting serum samples collected at 2.6-year follow-up were metabolomically profiled using the TMIC Prime Metabolomics Profiling Assay and pairwise metabolite ratios as the proxies of enzymatic reaction were calculated. Linear regression was used to identify metabolite ratio(s) associated with change in cartilage volume in each of the knee compartments with adjustment for age, sex, and BMI. The significance level was defined at α = 3.0 × 10−6 to control multiple testing. A total of 344 participants (51% females) were included in the study. The mean age was 62.83 ± 6.13 years and the mean BMI was 27.48 ± 4.41 kg/m2 at baseline. The average follow-up time was 10.84 ± 0.66 years. Cartilage volume was reduced by 1.34 ± 0.72%, 1.06 ± 0.58%, and 0.98 ± 0.46% per year in the medial, lateral, and patellar compartments, respectively. Our data showed that the increased ratios of hexadecenoylcarnitine (C16:1) to tetradecanoylcarnitine (C14) and C16:1 to dodecanoylcarnitine (C12) were associated with 0.12 ± 0.02% reduction per year in patellar cartilage volume (both p < 3.03 × 10−6). In conclusion, our data suggested that alteration of long chain fatty acid β-oxidation was involved in patellar cartilage loss. While confirmation is needed, the ratios of C16:1 to C14 and C12 might be used to predict long-term cartilage loss. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Association between socioeconomic status and joint replacement of the hip and knee: a population‐based cohort study of older adults in Tasmania.
- Author
-
Munugoda, Ishanka P., Brennan‐Olsen, Sharon L., Wills, Karen, Cai, Guoqi, Graves, Stephen E., Lorimer, Michelle, Cicuttini, Flavia M., Callisaya, Michele L., Aitken, Dawn, and Jones, Graeme
- Subjects
KNEE osteoarthritis ,REPORTING of diseases ,HIP osteoarthritis ,TOTAL hip replacement ,TOTAL knee replacement ,CONFIDENCE intervals ,PAIN ,TIME ,RISK assessment ,SOCIAL classes ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,MIDDLE age ,SYMPTOMS - Abstract
Background: A socioeconomic gradient exists in the utilisation of total hip replacements (THR) and total knee replacements (TKR) for osteoarthritis. However, the relations between socioeconomic status (SES) and time to THR or TKR is unknown. Aim: To describe the association between SES and time to THR and TKR. Methods: One thousand and seventy‐two older adults residing in Tasmania, Australia, were studied. Incident primary THR and TKR were determined by data linkage to the Australian Orthopaedic Association National Joint Replacement Registry. At baseline, each participant's area‐level SES was determined using the Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD) from the Australian Bureau of Statistics' 2001 census data. The IRSAD was analysed in two ways: (i) categorised into quartiles, whereby quartile 1 represented the most socioeconomically disadvantaged group; and (ii) the cohort dichotomised at the quartile 1 cut‐point. Results: The mean age was 63.0 (±7.5) years and 51% were women. Over the median follow up of 12.9 (interquartile range: 12.2–13.9) years, 56 (5%) participants had a THR and 79 (7%) had a TKR. Compared with the most disadvantaged quartile, less disadvantaged participants were less likely to have a THR (i.e. less disadvantaged participants had a longer time to THR; hazard ratio (HR): 0.56; 95% confidence interval (CI) 0.32, 1.00) but not TKR (HR: 0.90; 95% CI 0.53, 1.54). However, the former became non‐significant after adjustment for pain and radiographic osteoarthritis, suggesting that the associations may be mediated by these factors. Conclusions: The present study suggests that time to joint replacement was determined according to the symptoms/need of the participants rather than their SES. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. The association between change in bone marrow lesion size and change in tibiofemoral cartilage volume and knee symptoms.
- Author
-
Cai, Guoqi, Aitken, Dawn, Laslett, Laura L, Hill, Catherine, Wluka, Anita E, March, Lyn, Cicuttini, Flavia, Pelletier, Jean-Pierre, Martel-Pelletier, Johanne, and Jones, Graeme
- Subjects
- *
CARTILAGE , *KNEE diseases , *KNEE pain , *CONFIDENCE intervals , *MAGNETIC resonance imaging , *COMPARATIVE studies , *OSTEOARTHRITIS , *DESCRIPTIVE statistics , *BONE marrow diseases , *SYMPTOMS - Abstract
Objective To describe the association between change in subchondral bone marrow lesions (BMLs) and change in tibiofemoral cartilage volume and knee symptoms in patients with symptomatic knee OA. Methods In total, 251 participants (mean 61.7 years, 51% female) were included. Tibiofemoral cartilage volume was measured at baseline and 24 months, and BML size at baseline, 6 and 24 months. Knee pain and function scores were evaluated at baseline, 6 and 24 months. Change in total and compartment-specific BML size was categorized according to the Least Significance Criterion. Linear mixed-effects models were used to evaluate the associations of change in BMLs over 6 and 24 months with change in cartilage volume over 24 months and knee symptoms over 6 and 24 months. Results Total BML size enlarged in 26% of participants, regressed in 31% and remained stable in 43% over 24 months. Compared with stable BMLs in the same compartment, enlarging BMLs over 24 months were associated with greater cartilage loss (difference: −53.0mm3, 95% CI: −100.0, −6.0), and regressing BMLs were not significantly associated with reduced cartilage loss (difference: 32.4mm3, 95% CI: −8.6, 73.3) over 24 months. Neither enlargement nor regression of total BML size over 6 and 24 months was associated with change in knee pain and function over the same time intervals. Conclusions In subjects with symptomatic knee osteoarthritis and BMLs, enlarging BMLs may lead to greater cartilage loss but regressing lesions are not associated with reduced cartilage loss while neither is associated with change in knee symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
8. Differentiating knee pain phenotypes in older adults: a prospective cohort study.
- Author
-
Pan, Feng, Tian, Jing, Cicuttini, Flavia, Jones, Graeme, and Aitken, Dawn
- Subjects
EMOTIONS ,KNEE pain ,KNEE ,KNEE diseases ,LONGITUDINAL method ,MAGNETIC resonance imaging ,OSTEOARTHRITIS ,QUESTIONNAIRES ,SEX distribution ,STATISTICS ,PHENOTYPES ,COMORBIDITY ,DATA analysis ,EDUCATIONAL attainment ,PAIN measurement ,BODY mass index ,LIFESTYLES ,DISEASE prevalence ,DISEASE exacerbation ,PATIENTS' attitudes ,ATTITUDES toward illness ,DIAGNOSIS ,THERAPEUTICS - Abstract
Objective To identify and validate knee pain phenotypes in an older population across different pain-related domains over 10.7 years. Methods A total of 963 participants (mean age 63 years) from a population-based older adult cohort study were studied at baseline and followed up at 2.6 (n = 875), 5.1 (n = 768) and 10.7 years (n = 563). Baseline demographic, psychological, lifestyle and comorbidities data were obtained and MRI was performed to measure knee structural pathology. WOMAC pain and pain at multiple sites were assessed by questionnaires at each time-point. Latent class analysis was used to identify knee pain phenotypes, considering sex, BMI, emotional problems, education level, comorbidities, number of painful sites and knee structural pathology. Results Three pain phenotypes were identified: Class 1: high prevalence of emotional problems and low prevalence of structural damage (25%); Class 2: high prevalence of structural damage and low prevalence of emotional problems (20%); Class 3: low prevalence of emotional problems and low prevalence of structural damage (55%). Participants within Class 1 and 2 had greater BMI, more comorbidities, a higher prevalence of radiographic knee OA and knee structural pathology compared with Class 3. Furthermore, compared with Class 2 and 3, WOMAC pain and number of painful sites were consistently greater at each time-point over 10.7 years in Class 1. Results were similar when the analyses were restricted to participants with radiographic knee OA. Conclusion Psychological and structural factors interact with each other to exacerbate pain perception, suggesting that tailored treatment approaches for older people with knee pain in clinical practice are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
9. Predictors of pain severity trajectory in older adults: a 10.7-year follow-up study.
- Author
-
Pan, F., Tian, J., Aitken, D., Cicuttini, F., Jones, G., Pan, Feng, Tian, Jing, Aitken, Dawn, Cicuttini, Flavia, and Jones, Graeme
- Abstract
Objectives: To identify distinct pain trajectories over 10.7 years and to examine predictors of identified pain trajectories in an older population and those with radiographic knee osteoarthritis (ROA).Methods: 963 participants (aged 50-80 years) from a population-based cohort had baseline demographic, psychological, lifestyle and comorbidities data collected. T1-and T2-weighted magnetic resonance imaging (MRI) of the right knee was performed to measure knee structural pathology-cartilage defects, bone marrow lesions (BMLs) and effusion-synovitis. Group-based trajectory modelling (GBTM) was applied to identify trajectories of knee pain over 10.7 years measured by Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC).Results: Three distinct pain trajectories were defined: 'Minimal pain' (n = 501, 52%), 'Mild pain' (n = 329, 34%) and 'Moderate pain' (n = 165, 14%). In multivariable analysis, having cartilage defects, BMLs and effusion-synovitis were associated with an increased risk of being in the 'Mild pain' (relative risk [RR]: 1.40 to 1.92) and 'Moderate pain' trajectory (RR: 1.72 to 2.26), compared with the 'Minimal pain' trajectory. Being obese and having more painful sites were associated with 'Mild pain' and 'Moderate pain' trajectories, while unemployment, lower education level and presence of emotional problems were associated with 'Moderate pain' trajectory group. Similar results were found for those with ROA.Conclusion: Distinct pain trajectories identified suggest that homogeneous subgroups exist, which might be useful for phenotypic assessment for pain management, particularly in knee osteoarthritis. Structural pathology was associated with worse pain trajectories, suggesting that peripheral stimuli are critical for the development and maintenance of pain severity. Environmental and psychological factors may exacerbate pain perception. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
10. Vitamin D supplementation and inflammatory and metabolic biomarkers in patients with knee osteoarthritis: <italic>post hoc</italic> analysis of a randomised controlled trial.
- Author
-
Zheng, Shuang, Wang, Bing, Han, Weiyu, Zhu, Zhaohua, Wang, Xia, Jin, Xingzhong, Antony, Benny, Cicuttini, Flavia, Wluka, Anita, Winzenberg, Tania, Aitken, Dawn, Blizzard, Leigh, Jones, Graeme, and Ding, Changhai
- Subjects
BIOMARKERS ,C-reactive protein ,DIETARY supplements ,IMMUNOASSAY ,INFLAMMATORY mediators ,INTERLEUKINS ,KNEE diseases ,OSTEOARTHRITIS ,PROTEOLYTIC enzymes ,STATISTICS ,VITAMIN D ,VITAMIN D deficiency ,LEPTIN ,DATA analysis ,CHOLECALCIFEROL ,RANDOMIZED controlled trials ,ADIPONECTIN ,RESISTIN ,BLOOD ,PHARMACODYNAMICS - Abstract
The aim of this study was to determine whether vitamin D supplementation and maintaining vitamin D sufficiency are associated with changes in inflammatory and metabolic biomarkers in patients with knee osteoarthritis (OA) and vitamin D deficiency. A total of 413 participants with symptomatic knee OA and vitamin D deficiency were enrolled in a randomised, placebo-controlled trial and received 1·25 mg vitamin D
3 or placebo monthly for 24 months across two sites. In thispost hoc analysis, 200 participants from one site (ninety-four from the placebo group and 106 from the vitamin D group; mean age 63·1 (sd 7·3) years, 53·3 % women) were randomly selected for measurement of serum levels of inflammatory and metabolic biomarkers at baseline and 24 months using immunoassays. In addition, participants were classified into two groups according to serum 25-hydroxyvitamin D (25(OH)D) levels at months 3 and 24: (1) not consistently sufficient (25(OH)D≤50 nmol/l at either month 3 or 24,n 61), and (2) consistently sufficient (25(OH)D>50 nmol/l at both months 3 and 24,n 139). Compared with placebo, vitamin D supplementation had no significant effect on change in serum high-sensitive C-reactive protein, IL-6, IL-8, IL-10, leptin, adiponectin, resistin, adipsin and apelin. Being consistently vitamin D sufficient over 2 years was also not associated with changes in these biomarkers compared with not being consistently sufficient. Vitamin D supplementation and maintaining vitamin D sufficiency did not alter serum levels of inflammatory and metabolic biomarkers over 2 years in knee OA patients who were vitamin D insufficient, suggesting that they may not affect systemic inflammation in knee OA patients. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
11. Lysophosphatidylcholines to phosphatidylcholines ratio predicts advanced knee osteoarthritis.
- Author
-
Weidong Zhang, Guang Sun, Aitken, Dawn, Likhodii, Sergei, Ming Liu, Martin, Glynn, Furey, Andrew, Randell, Edward, Rahman, Proton, Jones, Graeme, and Guangju Zhai
- Subjects
LECITHIN metabolism ,BIOMARKERS ,BRANCHED chain amino acids ,CONFIDENCE intervals ,KNEE ,KNEE diseases ,LONGITUDINAL method ,OSTEOARTHRITIS ,PHOSPHOLIPIDS ,REGRESSION analysis ,RESEARCH funding ,STATISTICS ,DATA analysis ,CROSS-sectional method ,PROPORTIONAL hazards models ,RECEIVER operating characteristic curves ,HISTIDINE ,DATA analysis software ,DESCRIPTIVE statistics ,KAPLAN-Meier estimator ,LOG-rank test - Abstract
Objective. To identify novel biomarker(s) for predicting advanced knee OA. Methods. Study participants were derived from the Newfoundland Osteoarthritis Study and the Tasmania Older Adult Cohort Study. All knee OA cases were patients who underwent total knee replacement (TKR) due to primary OA. Metabolic profiling was performed on fasting plasma. Four thousand and eighteen plasma metabolite ratios that were highly correlated with that in SF in our previous study were generated as surrogates for joint metabolism. Results. The discovery cohort included 64 TKR cases and 45 controls and the replication cohorts included a cross-sectional cohort of 72 TKR cases and 76 controls and a longitudinal cohort of 158 subjects, of whom 36 underwent TKR during the 10-year follow-up period. We confirmed the previously reported association of the branched chain amino acids to histidine ratio with advanced knee OA (P = 9.3 x 10
-7 ) and identified a novel metabolic marker--the lysophosphatidylcholines (lysoPCs) to phosphatidylcholines (PCs) ratio--that was associated with advanced knee OA (P = 1.5 x 10-7 ) after adjustment for age, sex and BMI. When the subjects of the longitudinal cohort were categorized into two groups based on the optimal cut-off of the ratio of 0.09, we found the subjects with the ratio ≽0.09 were 2.3 times more likely to undergo TKR than those with the ratio <0.09 during the 10-year follow-up (95% CI: 1.2, 4.3, P = 0.02). Conclusion. We identified the ratio of lysoPCs to PCs as a novel metabolic marker for predicting advanced knee OA. Further studies are required to examine whether this ratio can predict early OA change. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
12. Maintaining Vitamin D Sufficiency Is Associated with Improved Structural and Symptomatic Outcomes in Knee Osteoarthritis.
- Author
-
Zheng, Shuang, Jin, Xingzhong, Cicuttini, Flavia, Wang, Xia, Zhu, Zhaohua, Wluka, Anita, Han, Weiyu, Winzenberg, Tania, Antony, Benny, Aitken, Dawn, Blizzard, Leigh, Jones, Graeme, and Ding, Changhai
- Subjects
- *
OSTEOARTHRITIS , *VITAMIN D deficiency , *CLINICAL trials , *KNEE diseases , *MAGNETIC resonance imaging , *THERAPEUTIC use of vitamin D , *COMPARATIVE studies , *RESEARCH methodology , *MEDICAL cooperation , *QUESTIONNAIRES , *RESEARCH , *VITAMIN D , *EVALUATION research , *BLIND experiment , *DISEASE progression , *DISEASE complications - Abstract
Background: The aim of this study was to describe whether maintaining sufficient serum vitamin D levels in people with knee osteoarthritis and baseline vitamin D insufficiency has an association with change in knee structures and symptoms over 2 years.Methods: Participants (n = 413, mean age 63.2 years) with symptomatic knee osteoarthritis and vitamin D insufficiency were enrolled in a clinical trial. In all, 340 participants (82.3%) completed the study, with 25-hydroxyvitamin D [25(OH)D] measurements at baseline and months 3 and 24. Participants were classified as consistently insufficient [serum 25(OH)D ≤50 nmol/L at months 3 and 24, n = 45], fluctuating [25(OH)D >50 nmol/L at either point, n = 68), and consistently sufficient [25(OH)D >50 nmol/L at months 3 and 24, n = 226] groups. Knee cartilage volume, cartilage defects, bone marrow lesions, and effusion-synovitis volume were assessed using MRI at baseline and month 24. Knee symptoms were assessed at baseline and months 3, 6, 12, and 24 using the Western Ontario and McMaster Universities Arthritis Index.Results: The consistently sufficient group had significantly less loss of tibial cartilage volume (β 2.1%; 95% confidence interval [CI], 0.3%, 3.9%), less increase in effusion-synovitis volume (β -2.5 mL; 95 CI%, -4.7, -0.2 mL), and less loss of Western Ontario and McMaster Universities Arthritis Index physical function (β -94.2; 95% CI, -183.8, -4.5) compared with the consistently insufficient group in multivariable analyses. In contrast, there were no significant differences in these outcomes between the fluctuating and consistently insufficient groups. Changes in cartilage defects, bone marrow lesions, and knee pain were similar between groups.Conclusion: This post hoc analysis suggests beneficial effects of maintaining vitamin D sufficiency on cartilage loss, effusion-synovitis, and physical function in people with knee osteoarthritis. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.